Where to buy Natalizumab

Natalizumab is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Natalizumab increases the risk of progressive multifocal leukoencephalopathy (PML). When initiating and continuing treatment with natalizumab, it is important to discuss with your doctor whether the expected benefits of natalizumab are sufficient to outweigh this risk. Natalizumab is also used to treat moderate to severe Crohn's disease, primarily to reduce the signs and symptoms of Crohn's disease, especially in patients who do not have or cannot use commonly used Crohn's disease drugs and tumor necrosis factor inhibitor drugs.

Because patients are at risk of contractingPML virus while receiving natalizumab, natalizumab is only available through a restricted distribution program called the TOUCH Prescription Program. To receive natalizumab, you must talk to your doctor and understand the risks and benefits of natalizumab and agree to follow all instructions in the TOUCH prescription plan. Natalizumab is prescribed by doctors participating in the contact prescription program, provided by infusion centers participating in the contact prescription program, and provided to people participating in the contact prescription program; before the patient receives natalizumab, the doctor will explain to the patient the TOUCH prescription program and whether the TOUCH prescribing physician and patient registration form have been signed.

Natalizumab's original patent drug is not on the market in China and cannot be included in medical insurance. Domestic patients cannot yet purchase this drug. Currently, the generic drug natalizumab on the market overseas may cost more than 8,000 US dollars per box (the price may fluctuate due to exchange rates), which is very expensive. For more drug information and specific prices, please consult Yaode Medical Consultant.